Clinically, increased CD8+ TIL at the tumor-invasive margin improved prognosis and their intra-tumor counterpart, associated with an improved disease-free survival in type I and II EC, have been found more frequently in low-grade than in high grade tumors. Here, CD8A is linked to neoplasm.